Vaxcyte, Inc. — SC 13G/A Filings
20 SC 13G/A filings on record
This page lists all SC 13G/A filings submitted to the SEC by Vaxcyte, Inc. (PCVX), sorted by most recent first. Each row links to the full filing on EdgarLookup. Vaxcyte, Inc. has filed 20 SC 13G/A documents with the SEC since 2015. To view all SEC filings by Vaxcyte, Inc., see the full filings list.
All
10-K
10-Q
144
144/A
3
4
4/A
424B4
424B5
8-A12B
8-K
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
PRE 14A
S-1
S-1/A
S-1MEF
S-3ASR
S-8
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SC 13G/A | SC 13G/A | 0001104659-24-119302 | Nov 14, 2024 | — |
| SC 13G/A | — | 0000315066-24-002884 | Nov 12, 2024 | — |
| SC 13G/A | SC 13G/A | 0001104659-24-024008 | Feb 14, 2024 | — |
| SC 13G/A | SCHEDULE 13G/A | 0001104659-24-022214 | Feb 13, 2024 | — |
| SC 13G/A | — | 0000315066-24-001536 | Feb 9, 2024 | — |
| SC 13G/A | — | 0001086364-24-003180 | Jan 25, 2024 | — |
| SC 13G/A | SC 13G/A | 0001104659-23-021821 | Feb 14, 2023 | — |
| SC 13G/A | AMENDMENT TO FORM SC 13G | 0001387131-23-001764 | Feb 10, 2023 | — |
| SC 13G/A | — | 0000315066-23-002132 | Feb 9, 2023 | — |
| SC 13G/A | SCHEDULE 13G/A | 0001104659-23-017223 | Feb 9, 2023 | — |
| SC 13G/A | — | 0000834237-22-008927 | Mar 9, 2022 | — |
| SC 13G/A | SC 13G/A | 0001193125-22-042444 | Feb 15, 2022 | — |
| SC 13G/A | SC 13G/A | 0000905718-22-000349 | Feb 14, 2022 | — |
| SC 13G/A | SC 13G/A | 0001104659-22-021235 | Feb 14, 2022 | — |
| SC 13G/A | — | 0000315066-22-001242 | Feb 9, 2022 | — |
| SC 13G/A | AMENDED SC13G | 0001387131-22-000432 | Jan 18, 2022 | — |
| SC 13G/A | SC 13G/A | 0001104659-21-043924 | Mar 30, 2021 | — |
| SC 13G/A | SC 13G/A | 0001104659-21-024242 | Feb 16, 2021 | — |
| SC 13G/A | AMENDED ACQUISITION OF BENEFICIAL OWNERSHIP | 0001387131-21-002282 | Feb 12, 2021 | — |
| SC 13G/A | — | 0000315066-21-001325 | Feb 8, 2021 | — |